1320 related articles for article (PubMed ID: 25459294)
1. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways.
Park J; Min JS; Kim B; Chae UB; Yun JW; Choi MS; Kong IK; Chang KT; Lee DS
Neurosci Lett; 2015 Jan; 584():191-6. PubMed ID: 25459294
[TBL] [Abstract][Full Text] [Related]
2. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.
Zheng GM; Yu C; Yang Z
Int J Oncol; 2012 May; 40(5):1610-8. PubMed ID: 22246431
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells.
Park J; Choi H; Min JS; Park SJ; Kim JH; Park HJ; Kim B; Chae JI; Yim M; Lee DS
J Neurochem; 2013 Oct; 127(2):221-32. PubMed ID: 23815397
[TBL] [Abstract][Full Text] [Related]
4. LPS-induced iNOS expression in N9 microglial cells is suppressed by geniposide via ERK, p38 and nuclear factor-κB signaling pathways.
Zhang G; He JL; Xie XY; Yu C
Int J Mol Med; 2012 Sep; 30(3):561-8. PubMed ID: 22710392
[TBL] [Abstract][Full Text] [Related]
5. Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-kappaB signaling pathways in N9 microglia induced by lipopolysaccharide.
Zhang L; Wu C; Zhao S; Yuan D; Lian G; Wang X; Wang L; Yang J
Int Immunopharmacol; 2010 Mar; 10(3):331-8. PubMed ID: 20018257
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation.
Kim SU; Park YH; Min JS; Sun HN; Han YH; Hua JM; Lee TH; Lee SR; Chang KT; Kang SW; Kim JM; Yu DY; Lee SH; Lee DS
J Neuroimmunol; 2013 Jun; 259(1-2):26-36. PubMed ID: 23602274
[TBL] [Abstract][Full Text] [Related]
7. Deoxysappanone B, a homoisoflavone from the Chinese medicinal plant Caesalpinia sappan L., protects neurons from microglia-mediated inflammatory injuries via inhibition of IκB kinase (IKK)-NF-κB and p38/ERK MAPK pathways.
Zeng KW; Yu Q; Song FJ; Liao LX; Zhao MB; Dong X; Jiang Y; Tu PF
Eur J Pharmacol; 2015 Feb; 748():18-29. PubMed ID: 25530267
[TBL] [Abstract][Full Text] [Related]
8. The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways.
Lim JY; Won TJ; Hwang BY; Kim HR; Hwang KW; Sul D; Park SY
Eur J Pharmacol; 2010 Sep; 642(1-3):10-8. PubMed ID: 20534383
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-κB signaling pathways in N9 microglia.
Zhao S; Zhang L; Lian G; Wang X; Zhang H; Yao X; Yang J; Wu C
Int Immunopharmacol; 2011 Apr; 11(4):468-74. PubMed ID: 21220057
[TBL] [Abstract][Full Text] [Related]
10. (+)-Catechin Attenuates NF-κB Activation Through Regulation of Akt, MAPK, and AMPK Signaling Pathways in LPS-Induced BV-2 Microglial Cells.
Syed Hussein SS; Kamarudin MN; Kadir HA
Am J Chin Med; 2015; 43(5):927-52. PubMed ID: 26227399
[TBL] [Abstract][Full Text] [Related]
11. Paeonol from Hippocampus kuda Bleeler suppressed the neuro-inflammatory responses in vitro via NF-κB and MAPK signaling pathways.
Himaya SW; Ryu B; Qian ZJ; Kim SK
Toxicol In Vitro; 2012 Sep; 26(6):878-87. PubMed ID: 22542583
[TBL] [Abstract][Full Text] [Related]
12. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways.
Zeng KW; Wang S; Dong X; Jiang Y; Tu PF
Phytomedicine; 2014 Feb; 21(3):298-306. PubMed ID: 24055519
[TBL] [Abstract][Full Text] [Related]
13. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
14. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage.
Kim HG; Yoon DH; Lee WH; Han SK; Shrestha B; Kim CH; Lim MH; Chang W; Lim S; Choi S; Song WO; Sung JM; Hwang KC; Kim TW
J Ethnopharmacol; 2007 Dec; 114(3):307-15. PubMed ID: 17936530
[TBL] [Abstract][Full Text] [Related]
15. HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways.
Zhou Y; Wu Z; Cao X; Ding L; Wen Z; Bian JS
Pharmacol Res; 2016 Sep; 111():885-895. PubMed ID: 27507578
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells.
Wang YP; Wu Y; Li LY; Zheng J; Liu RG; Zhou JP; Yuan SY; Shang Y; Yao SL
J Neuroinflammation; 2011 Aug; 8():95. PubMed ID: 21831303
[TBL] [Abstract][Full Text] [Related]
17. Daphnetin attenuates microglial activation and proinflammatory factor production via multiple signaling pathways.
Yu W; Wang H; Ying H; Yu Y; Chen D; Ge W; Shi L
Int Immunopharmacol; 2014 Jul; 21(1):1-9. PubMed ID: 24747094
[TBL] [Abstract][Full Text] [Related]
18. A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-κB and JNK MAPK signaling in microglial BV2 cells.
Cai B; Seong KJ; Bae SW; Chun C; Kim WJ; Jung JY
Int Immunopharmacol; 2018 Aug; 61():204-214. PubMed ID: 29890414
[TBL] [Abstract][Full Text] [Related]
19. The role of autophagy in pro-inflammatory responses of microglia activation via mitochondrial reactive oxygen species in vitro.
Ye J; Jiang Z; Chen X; Liu M; Li J; Liu N
J Neurochem; 2017 Jul; 142(2):215-230. PubMed ID: 28407242
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
